Vogenx awards director Pieraccini 50,000 options
The award vests in annual installments through October 2, 2029, subject to the director's continued service through each vesting date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vogenx, Inc. director Peter Pieraccini received a direct award of 50,000 stock options to acquire common stock on October 2, 2026. The options have an exercise price of $18.23 per share and expire on October 2, 2036. They vest in three annual installments, subject to his continued service through each vesting date. Pieraccini's reported direct option position after the award was 50,000 options.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 50,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The options vest over a three -year period in three equal annual installments of 33.33% (16,666 shares on October 2, 2027, 16,667 shares on October 2, 2028 and 16,667 shares on October 2, 2029), subject to the Reporting Person's continued service to the Issuer through each vesting date.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
exercise price financial
annual installments technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did VOGX director Peter Pieraccini receive?
When do Peter Pieraccini's VOGX options vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.